Search research articles
Contact Us
Filters
Showing results (121-130 of 127) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 127 results.
The Lancet. Respiratory Medicine
|
March 1, 2026
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a multicentre, randomised, sham-controlled trial
Anne E Holland, Mariana Hoffman, Tamera J Corte, et al.
The Medical Journal of Australia
|
February 2, 2018
Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary
Helen E Jo, Jyotika D Prasad, Lauren K Troy, et al.
Thorax
|
September 24, 2024
Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease
Andrew Li, Alan Teoh, Lauren Troy, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
September 9, 2020
Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells
Soraia C Abreu, Thomas H Hampton, Evan Hoffman, et al.
Respirology (Carlton, Vic.)
|
November 24, 2020
Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand
Adelle S Jee, Robert Sheehy, Peter Hopkins, et al.
The Lancet. Respiratory Medicine
|
September 8, 2022
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
Joshua J Solomon, Sonye K Danoff, Felix A Woodhead, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
January 14, 2026
Multi-omics to study chronic respiratory diseases and viral infections
Sobia Idrees, Hao Chen, Tayyaba Sadaf, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 127) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 127 results.
The Lancet. Respiratory Medicine
|
March 1, 2026
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a multicentre, randomised, sham-controlled trial
Anne E Holland, Mariana Hoffman, Tamera J Corte, et al.
The Medical Journal of Australia
|
February 2, 2018
Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary
Helen E Jo, Jyotika D Prasad, Lauren K Troy, et al.
Thorax
|
September 24, 2024
Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease
Andrew Li, Alan Teoh, Lauren Troy, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
September 9, 2020
Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells
Soraia C Abreu, Thomas H Hampton, Evan Hoffman, et al.
Respirology (Carlton, Vic.)
|
November 24, 2020
Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand
Adelle S Jee, Robert Sheehy, Peter Hopkins, et al.
The Lancet. Respiratory Medicine
|
September 8, 2022
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
Joshua J Solomon, Sonye K Danoff, Felix A Woodhead, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
January 14, 2026
Multi-omics to study chronic respiratory diseases and viral infections
Sobia Idrees, Hao Chen, Tayyaba Sadaf, et al.
Page
of 13